Jaguar Health, Inc. — Form 8-K
Filed July 1, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 72/100
What the filing says
On June 25, 2026, Jaguar Health completed conversion of all outstanding Series O Preferred Stock into 4,857,211 shares of Common Stock at a conversion ratio of 3.209 shares per preferred share. The company also issued warrant conversion shares; warrant holders can now exercise for up to 839,000 common shares (comprising 68,593 original warrant shares and 770,407 conversion shares).
Why this rating
Massive share dilution (4.86M new shares) on a $3.8M market-cap micro-cap company is material. Conversion was pre-announced and non-cash; changes capital structure significantly but is mechanical conversion, not new funding or loss.
View original filing on SEC.gov ↗
See more from July 1, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.